Understanding how early schizophrenia patients respond to antipsychotic treatment
A Multidimensional Dissection of Antipsychotic Treatment Response in Early Schizophrenia
This study is looking into why some people with early schizophrenia don’t get better with antipsychotic medications, using special brain scans to understand what’s happening in their brains, so we can find better treatments for those who need them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11079542 on NIH RePORTER |
What this research studies
This research investigates the reasons why some individuals with early schizophrenia do not respond well to antipsychotic medications. By using advanced neuroimaging techniques, the study aims to uncover the biological mechanisms that influence treatment effectiveness. Patients will undergo high-field MRI scans to analyze changes in brain chemistry and structure associated with their treatment responses. The goal is to improve current therapies and develop new ones for those who struggle with existing options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with early schizophrenia who are currently undergoing antipsychotic treatment.
Not a fit: Patients who are not diagnosed with schizophrenia or those who have not started antipsychotic treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for individuals with early schizophrenia, improving their quality of life.
How similar studies have performed: Previous research using neuroimaging techniques has shown promise in understanding treatment responses in psychiatric disorders, suggesting potential for success in this approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Sarpal, Deepak K — University of Pittsburgh at Pittsburgh
- Study coordinator: Sarpal, Deepak K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.